IRAK3 (interleukin 1 receptor associated kinase 3) functions as a critical negative regulator of innate immune signaling and inflammation. This pseudokinase acts as a checkpoint molecule that inhibits inflammatory responses by preventing dissociation of IRAK1 and IRAK4 from Toll-like receptor and IL-1 receptor signaling complexes 1. IRAK3 contains a unique guanylate cyclase center that generates low levels of cyclic GMP, which is essential for suppressing NFκB activity and reducing pro-inflammatory cytokines including TNF-α and IL-6 1. The protein demonstrates dual regulatory roles depending on context - while generally anti-inflammatory, it can positively regulate certain cytokines like IL-6 and chemokines during specific inflammatory conditions 2. IRAK3 expression is significantly elevated in various inflammatory diseases including rheumatoid arthritis, where reduced expression correlates with higher disease activity 34. In experimental arthritis models, IRAK3 deficiency accelerates disease progression and increases inflammatory markers, demonstrating its protective role 4. The protein also serves as a biomarker for severe traumatic brain injury, with elevated serum levels correlating with injury severity and neurological outcomes 5. IRAK3's anti-inflammatory function makes it a potential therapeutic target for metabolic disorders and inflammatory diseases 67.